GW Pharmaceuticals plans to recruit approximately 116 children with Lennox-Gastaut Syndrome to participate in a new clinical trial. The study … More
Four new studies on CBD and clobazam have conflicting results.
The approval of EPIDYOLEX® marks a significant milestone, offering patients and their families the first in a new class of epilepsy medicines and the first and only EMA-approved CBD medicine to treat two severe and life-threatening forms of childhood-onset epilepsy.”
First drug (Epidiolex) containing purified substance derived from marijuana was approved by U.S. FDA: We’ll continue to support rigorous scientific research on potential medical uses of marijuana-derived products,” said FDA Commissioner Scott .Gottlieb
Drug company earning multi-millions on MS med containing only 2 ingredients – THC and CBD ready to launch epilepsy drug this fall & now racing to develop CBD drugs for schizophrenia, #autism & other hard-to treat diseases.